title: Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.
abstract: OBJECTIVE
  Due to a lack of clinical trials, scientific evidence regarding the management of patients with chronic heart failure and preserved left ventricular function (PLVF) is scarce. The EuroHeart Failure Survey provided information on the characteristics, treatment and outcomes of patients with PLVF as compared to patients with a left ventricular systolic dysfunction (LVSD).
  
  
  RESULTS
  We performed a secondary analysis using data from the EuroHeart Failure Survey, only including patients with a measurement of LV function (n = 6806). We selected two groups: patients with LVSD (54%) and patients with a PLVF (46%). Patients with a PLVF were, on average, 4 years older and more often women (55% vs. 29%, respectively, p < 0.001) as compared to LVSD patients, and were more likely to have hypertension (59% vs. 50%, p < 0.001) and atrial fibrillation (25% vs. 23%, p = 0.01). PLVF patients received less cardiovascular medication compared to PLVF patients, with the exception of calcium antagonists. Multivariate analysis revealed that LVSD was an independent predictor for mortality, while no differences in treatment effect on mortality between the two groups was observed. A sensitivity analysis, using different thresholds to separate patients with and without LVSD revealed comparable findings.
  
  
  CONCLUSIONS
  In the EuroHeart Failure Survey, a high percentage of heart failure patients had PLVF. Although major clinical differences were seen between the groups, morbidity and mortality was high in both groups.
authors.affiliation: Department of Cardiology, Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands.
authors.forename: M J
authors.initials: MJ
authors.lastname: Lenzen
authors.forename: W J M
authors.initials: WJ
authors.lastname: Scholte op Reimer
authors.forename: E
authors.initials: E
authors.lastname: Boersma
authors.forename: P J M J
authors.initials: PJ
authors.lastname: Vantrimpont
authors.forename: F
authors.initials: F
authors.lastname: Follath
authors.forename: K
authors.initials: K
authors.lastname: Swedberg
authors.forename: J
authors.initials: J
authors.lastname: Cleland
authors.forename: M
authors.initials: M
authors.lastname: Komajda
mesh_terms: D000368:Aged; D005260:Female; D006306:Health Surveys; D006333:Heart Failure / Q000188:drug therapy / Q000401:mortality* / Q000503:physiopathology; D006760:Hospitalization; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D016019:Survival Analysis; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000401:mortality* / Q000503:physiopathology; D016277:Ventricular Function, Left / Q000502:physiology